La Salle St. Investment Advisors, LLC Abb Vie Inc. Transaction History
La Salle St. Investment Advisors, LLC
- $255 Million
- Q3 2024
A detailed history of La Salle St. Investment Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, La Salle St. Investment Advisors, LLC holds 5,756 shares of ABBV stock, worth $949,682. This represents 0.45% of its overall portfolio holdings.
Number of Shares
5,756
Previous 4,971
15.79%
Holding current value
$949,682
Previous $853,000
33.18%
% of portfolio
0.45%
Previous 0.43%
Shares
8 transactions
Others Institutions Holding ABBV
# of Institutions
3,841Shares Held
1.25BCall Options Held
16.8MPut Options Held
12.2M-
Vanguard Group Inc Valley Forge, PA172MShares$28.3 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$22.5 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$13 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.1MShares$8.6 Billion0.84% of portfolio
-
Morgan Stanley New York, NY38.7MShares$6.39 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $292B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...